RELIGARE258.01

Religare Enterprises Ltd.

· Banking & Finance
₹ CrorePeersSTARHEALTHPSBPRUDENTSHAREINDIASOUTHBANKSTYLMAHSCOOTERTMB
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Revenue Growth+18.0+15.0
EBITDA Growth-5.8-54.8
EBIT Growth-3.5-62.7
Net Income Growth-47.2-60.1
EPS Growth-46.8-31.7
Total Assets Growth+17.2+29.2
Total Equity Growth+8.3+12.8
Cash from Operations Growth+4.8+15.8
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.